
Conference Coverage
3 days ago
Busting ADHD Myths at APSARDLatest Content

Mental Health Grants Cut Then Restored in 24 Hours: Leading Organizations React to Environment of Uncertainty

Muscarinic Cholinergic Circuitry in Schizophrenia: Our Evolving Understanding

Is Artificial Intelligence Turning Athletes Into Robots and Robots Into Athletes?

The Element of Time in Psychotherapy

Enrollment and Dosing Complete in Phase 3 Trial of LPCN 1154 for Postpartum Depression

Shorts










Digital Edition
Podcasts
Continuing Medical Education
All News

Exploring the vital link between nutrition and mental health, this article highlights dietary strategies to enhance psychiatric well-being and cognitive function.

Inpatient psychiatry faces an epidemic of violence, highlighting systemic neglect and the urgent need for reform to protect health care workers.

Explore the evolving landscape of psychiatry as it reflects on past events, current challenges, and future predictions for mental health.

BioXcel Therapeutics submits an sNDA to the FDA for Igalmi to treat agitation in bipolar disorder and schizophrenia at home.

Explore how lifestyle psychiatry transforms depression treatment through nutrition, exercise, sleep, and social connections for holistic recovery and resilience.

Eating disorders pose a significant risk to athletes' health, highlighting the urgent need for awareness, support, and compassionate change in sports culture.

Researchers discuss precision medicine's potential to enhance opioid use disorder treatment.

Reflecting on Martin Luther King Jr.'s legacy, the article explores his insights on mental health, social justice, and the need for unity today.

Review the misperceptions patients and clinicians may have about ADHD diagnosis and treatment.

Experts discuss the complex relationship between ADHD treatment and substance use disorder.

Barry Herman, MD, shares insights on real-world data of online ADHD assessment tool and telepsychiatry.

Clinicians explore the complex relationship between ADHD medication and pregnancy, emphasizing individualized risk assessments for optimal maternal and child health.

A groundbreaking online ADHD assessment shows 78% agreement with clinician evaluations, enhancing access to mental health care for adults.

Seltorexant shows promise as a safe adjunctive treatment for patients with major depressive disorder and insomnia symptoms, with fewer weight changes than quetiapine XR.

Explore key insights on ADHD treatment barriers and the long-term outcomes for adolescents diagnosed with the disorder.









































